Myomo, Inc (MYO): Debts to Book Capitalization

Corporate company logo of Myomo, Inc (MYO)

Myomo, Inc. (MYO) management demonstrates exceptional professionalism in the commercialization of robotics and transparency regarding Medicare. This debt-to-equity structure chart clearly illustrates financial stability, where 3.22 represents the current metric level. Rising demand for orthotics in the US is expanding the customer base, while a team of talented engineers develops innovative exoskeletons backed by a strong corporate culture.

Myomo, Inc. - MYO Debts to Book Capitalization (period 07/04/2022 - 10/28/2026)
Brand item of Myomo Inc

This ratio determines the proportion of debt obligations relative to the company's equity. It measures the degree of financial autonomy and the risk of credit load on the balance sheet. By analyzing the trend of the total debt-to-equity ratio, an investor assesses the stability of the financing structure. For Myomo, Inc. (MYO), this balance is critical when scaling the production of myoelectric exoskeletons. An optimal debt level ensures the development of the innovative rehabilitation niche without the threat of default.

Competitors of Myomo, Inc.

Boston Scientific - Debts to Book Capitalization|Debt to Book Value edwards.com EW|Debts to Book Capitalization RMD (ResMed)|PODD - Debts to Net Assets|ZBH: Debts to Book Capitalization|COO (CooperSurgical) - Debts to Book Capitalization|Debt to Book Capitalization Ratio Align Technology, Inc.|Debt to Book Capitalization Ratio globusmedical.com|TMDX (TransMedics Organ Care System) - Debts to Book Capitalization|Debts to Net Assets Alphatec Holdings ATEC|Artivion Inc (AORT) - Debt to Book Value|Debts to Book Capitalization Ratio Enovis Inc. ENOV|IART (Integra LifeSciences) - Debts to Book Capitalization|ESTA - Debts to Book Value|Debts to Book Capitalization Beta Bionics|Debt to Book Value Ratio IRADIMED Corp|EMBC - Debt to Book Value|Debt to Net Assets Ratio TNDM|Debt to Book Capitalization Ratio AXGN (AxoGen, Inc.)|Debt to Book Value si-bone.com (SIBN)|OFIX: Debts to Book Capitalization|Debts to Book Value Bioventus Inc BVS|OrthoPediatrics Inc. (KIDS) - Debts to Book Capitalization|TMCI - Debt to Book Value Ratio|Strata Critical Medical Inc - Debts to Book Capitalization|carlsmed.com (CARL) - Debts to Net Assets|Debts to Book Capitalization RXST|Debt to Book Value ClearPoint|Debts to Book Capitalization STXS|Debts to Book Capitalization STIM (Neuronetics, Inc)|Debt to Book Capitalization Ratio Sight Sciences, Inc. SGHT|OBIO - Debt to Book Capitalization Ratio|Debt to Book Value Anika (ANIK)|NSPR - Debt to Net Assets Ratio|Debts to Book Capitalization ZJYL|VANI (Vivani Medical) - Debts to Book Value|Xtant Medical Holdings, Inc. - Debt to Book Capitalization Ratio|Debt to Net Assets n1mtc.com (NMTC)|Debt to Book Value MODD|Debts to Book Capitalization Envoy Medical Inc. (COCH)|Debts to Book Capitalization VVOS|enVVeno Corp - Debts to Net Assets|Debt to Book Capitalization Ratio SINTX Technologies|TNON: Debts to Book Capitalization Ratio|LFWD (Lifeward) - Debt to Book Capitalization Ratio|Autonomix Medical (AMIX) - Debt to Book Value|Debts to Book Capitalization IVF (INVO Bioscience, Inc.)|Debts to Book Value BBLG|Debt to Book Capitalization Ratio Axonics, Inc. AXNX|Debt to Book Value Ratio biolase.com BIOL|Debt to Book Value Dynatronics (DYNT)|Paragon 28 Inc. - Debt to Book Capital|INVO: Debt to Book Capitalization Ratio